Clinical trial results

Explore the landscape of Clinical trial results in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial results to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

CSPC to Unveil Data From 8 Oncology Trials at ESMO Congress 2026 – Anbenitamab Phase III Results Headline Two Late‑Breaking Abstracts
CompanyDrug

CSPC to Unveil Data From 8 Oncology Trials at ESMO Congress 2026 – Anbenitamab Phase III Results Headline Two Late‑Breaking Abstracts

CSPC Pharmaceutical Group Limited (HKG: 1093) announced in a voluntary announcement that it will present the latest updates from 8 clinical trials at the European Society for Medical Oncology (ESMO)…

FDA Approves Priovant's LISRAYA (Brepocitinib) for Adult Dermatomyositis – First Oral Targeted JAK1/TYK2 Therapy in the Indication

FDA Approves Priovant’s LISRAYA (Brepocitinib) for Adult Dermatomyositis – First Oral Targeted JAK1/TYK2 Therapy in the Indication

AnnJi Advances AJ201 into Pivotal Phase 3 ROMA‑KD Trial – The Only Investigational Therapy for SBMA in Late‑Stage Development Worldwide

AnnJi Advances AJ201 into Pivotal Phase 3 ROMA‑KD Trial – The Only Investigational Therapy for SBMA in Late‑Stage Development Worldwide

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Abbisko Therapeutics to Present CSF-1R Inhibitor ABSK021 Data at CTOS Annual Meeting

CompanyDrug

Ascentage Pharma’s Olverembatinib Showcases Promising Results at ASH Annual Meeting

CompanyDrug

Sirnaomics’ STP705 Demonstrates Positive Results in Phase I Focal Fat Reduction Study

CompanyDrug

Shanghai Henlius Biotech’s HanSiZhuang Shows Positive Results in Phase III ASTRUM-002 Study

CompanyDrug

Roche’s Gene Therapy Elevidys Misses Primary Endpoint in DMD Trial

CompanyDrug

Yirui Pharmaceutical’s YR001 Completes Successful Phase I Clinical Study in the US

CompanyDrug

Novartis Announces Positive Interim Results for Atrasentan in IgA Nephropathy Phase III Study

CompanyDrug

Innovent Biologics’ Mazdutide Shows Promising Weight Loss Results in Phase II Trial

Show More